The platform analyses gene expression and cell states specific to individual cells, offering insights for disease diagnosis.
Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback